OKYO Pharma Ltd（OKYO）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-07-28 | 6-K | — | SEC |
| 2026-07-27 | 6-K | — | SEC |
| 2026-07-23 | 6-K | — | SEC |
| 2026-07-23 | 6-K | — | SEC |
| 2026-07-22 | 6-K | — | SEC |
| 2026-07-22 | 6-K | — | SEC |
| 2026-07-22 | 6-K | — | SEC |
| 2026-07-21 | 6-K | — | SEC |
| 2026-07-21 | 6-K | — | SEC |
| 2026-07-20 | 6-K | — | SEC |
| 2026-07-08 | 6-K | — | SEC |
| 2026-07-07 | 6-K | — | SEC |
| 2026-05-19 | 6-K | — | SEC |
| 2026-04-29 | 6-K | — | SEC |
| 2026-04-07 | 6-K | — | SEC |
| 2026-03-19 | 6-K | — | SEC |
| 2026-03-19 | 6-K | — | SEC |
| 2026-03-19 | 6-K | — | SEC |
| 2026-03-18 | 6-K | — | SEC |
| 2026-03-12 | 6-K | — | SEC |
| 2026-02-23 | 6-K | — | SEC |
| 2026-02-13 | 6-K | — | SEC |
| 2026-02-13 | 6-K | — | SEC |
| 2026-02-12 | 6-K | — | SEC |
| 2026-02-11 | 6-K | — | SEC |
| 2026-02-11 | 6-K | — | SEC |
| 2026-02-10 | 6-K | — | SEC |
| 2026-01-30 | 6-K | — | SEC |
| 2026-01-30 | 6-K | — | SEC |
| 2026-01-28 | 6-K | — | SEC |
| 2026-01-23 | 6-K | — | SEC |
| 2026-01-05 | 6-K | — | SEC |
| 2025-12-19 | 6-K | — | SEC |
| 2025-12-15 | 6-K | — | SEC |
| 2025-12-11 | 6-K | — | SEC |
| 2025-12-03 | 6-K | — | SEC |
| 2025-11-21 | 6-K | — | SEC |
| 2025-11-18 | 6-K | — | SEC |
| 2025-10-29 | 6-K | — | SEC |
| 2025-10-16 | 6-K | — | SEC |
| 2025-09-22 | 6-K | — | SEC |
| 2025-07-17 | 6-K | — | SEC |
| 2025-07-16 | 6-K | — | SEC |
| 2025-06-11 | 6-K | — | SEC |
| 2025-05-19 | 6-K | — | SEC |
| 2025-05-01 | 6-K | — | SEC |
| 2025-04-30 | 6-K | — | SEC |
| 2025-03-31 | 6-K | — | SEC |
| 2025-03-10 | 6-K | — | SEC |
| 2025-02-12 | 6-K | — | SEC |
| 2025-01-31 | 6-K | — | SEC |
| 2025-01-29 | 6-K | — | SEC |
| 2025-01-22 | 6-K | — | SEC |
| 2024-11-26 | 6-K | — | SEC |
| 2024-10-30 | 6-K | — | SEC |
| 2024-10-23 | 6-K | — | SEC |
| 2024-10-16 | 6-K | — | SEC |
| 2024-09-10 | 6-K | — | SEC |
| 2024-09-05 | 6-K | — | SEC |
| 2024-08-27 | 6-K | — | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。